You are viewing the site in preview mode
Skip to main content
|
Parameters
|
Baseline values
|
Explanation
|
Sensitivity analysis
|
Source
|
|---|
| | | |
Distribution
|
Parameters
| |
|---|
|
Model parameters
|
|
λ
| |
Force of infection (per day), calculated using*
| | | | |
|
1/r
|
365
|
Mean duration of infection (days) [6, 16]
|
N(μ,σ2)
|
μ=365
|
σ2=752
|
Consensus
|
|
p
|
5.7%
|
Prevalence at baseline [11]
|
Bin(n,p)
|
n=2519
|
|
[11]
|
|
α
| |
Effective testing rate (per day), calculated using†
| | | | |
|
c
|
22.2%
|
Coverage of testing uptake (per year) [11]
|
Bin(n,p)
|
n=2377
|
|
[11]
|
|
δ
|
8.0%
|
Treatment failure [17]
|
U(a,b)
|
a=0%
|
b=50%
|
Consensus
|
|
f
|
estimated
|
Fraction of women becoming infected with chlamydia who will develop PID
| | | | |
|
Input parameter
|
|
x
|
30.0%
|
Proportion of PID cases due to chlamydia in control group [11]
|
Bin(n,p)
|
n=23
|
|
[11]
|
-
*In the absence of the tria (α=0), to observe chlamydia prevalence p at steady state: .
-
†Reported uptake of chlamydia testing c during the follow-up period (outside of the trial) is reduced by the proportion with treatment failure δ, which results in the effective testing rate per day [18].
- N(μ,σ2), normal distribution (mean, variance); Bin(n,p), binomial distribution (size, probability); U(a,b), uniform distribution (minimum, maximum).